Defibrillators Market (2026 - 2033)

Defibrillators Market Summary

The global defibrillators market size was estimated at USD 8.5 billion in 2025 and is projected to grow from USD 9.2 billion in 2026 to USD 15.9 billion by 2033, growing at a CAGR of 8.1% from 2026 to 2033. The North America dominated the market, accounting for a revenue share of 42.0% in 2025. The market is primarily driven by the rising incidence of sudden cardiac arrest (SCA), increasing deployment of automated external defibrillators (AEDs), and continuous technological advancements in cardiac rhythm management devices. Growing public awareness and government-led initiatives to improve emergency response also contribute to the market expansion.

Source: Grand View Research, IR Documents, Primary Interviews, Paid Databases

To learn more about this report, Download Free Sample Report

The growing elderly population is contributing to a higher burden of cardiovascular diseases and cardiac arrhythmias, increasing the need for advanced cardiac rhythm management technologies. Older adults are at greater risk of sudden cardiac arrest and other heart conditions that require continuous monitoring and, in appropriate clinical cases, implantable or external defibrillation therapy. In 2025, according to the OECD, people aged 65 years and older accounted for approximately 22% of the European Union's population in 2024 and are projected to reach nearly 29% by 2050. The growing aging population is expected to increase the burden of cardiovascular diseases and cardiac arrhythmias, driving the need for advanced cardiac emergency care and defibrillation technologies.

Analyst Perspective

The defibrillators market is being shaped by the increasing emphasis on early intervention for sudden cardiac arrest and the modernization of emergency cardiac care infrastructure. Growing deployment of automated external defibrillators (AEDs) in public spaces, workplaces, educational institutions, and transportation hubs is improving access to life-saving treatment and strengthening market demand. At the same time, advancements in implantable defibrillators, including remote monitoring, wireless connectivity, and AI-assisted arrhythmia detection, are enhancing patient management and clinical outcomes. Rising investment in emergency medical services, favorable public-access defibrillation initiatives, and expanding healthcare infrastructure in emerging economies are expected to support broader adoption. Manufacturers focusing on innovative, reliable, and connected defibrillation technologies are well-positioned to strengthen their competitive advantage.

Product Insights

By product, the implantable cardioverter defibrillators (ICDs) segment held the largest market share, at around 52.0%, in 2025. The segment continues to lead the market due to the increasing prevalence of life-threatening cardiac arrhythmias and the growing use of ICDs for long-term prevention of sudden cardiac arrest in high-risk patients. Favorable clinical guidelines, expanding adoption of minimally invasive implantation procedures, and continuous technological advancements in remote monitoring and device longevity are further supporting market growth. For instance, in January 2024, BIOTRONIK announced that over 100,000 implantable cardioverter defibrillators equipped with its DX Technology had been implanted worldwide. The milestone highlights the growing adoption of single-lead ICD systems capable of direct atrial sensing and continuous monitoring of atrial fibrillation.

The external defibrillators segment is anticipated to register the fastest CAGR during the forecast period. The growing deployment of automated external defibrillators (AEDs) across public spaces, workplaces, schools, and emergency medical services is accelerating market growth. Technological advancements, including connected platforms, enhanced patient monitoring, and simplified operations, are improving emergency response capabilities. For instance, in June 2024, Stryker launched the LIFEPAK 35 monitor/defibrillator for emergency medical services and hospitals. The device incorporates advanced patient monitoring, connected technologies, and workflow enhancements to improve clinical decision-making during cardiac emergencies.

End Use Insights

By end use, the hospitals segment held the largest market revenue share of more than 60.0% in 2025. Hospitals remain the largest end users of defibrillators owing to the high volume of cardiac emergencies, availability of specialized cardiac care units, and increasing number of electrophysiology procedures and cardiac surgeries. Both implantable and external defibrillators are routinely used across emergency departments, intensive care units, and operating rooms to provide immediate treatment for life-threatening arrhythmias and sudden cardiac arrest. Continued investments in advanced cardiac care infrastructure further support segment growth.

The public access market segment is anticipated to register the fastest CAGR during forecast period. Governments, healthcare organizations, and private institutions are expanding public access defibrillation programs to improve survival rates following sudden cardiac arrest. Increasing installation of AEDs in airports, railway stations, schools, sports venues, shopping malls, and workplaces, together with public CPR and AED training initiatives, continues to accelerate market adoption. For instance, in March 2024, tryker launched the LIFEPAK CR2 Automated External Defibrillator (AED) in India during Criticare 2024. Designed for public environments, the device incorporates QUIK-STEP electrodes, ClearVoice technology, and real-time CPR guidance to support rapid bystander response during cardiac emergencies.

Regional Insights

North America held the largest revenue share of over 42.0% in 2025, supported by the high prevalence of cardiovascular diseases, widespread availability of advanced cardiac care services, favorable reimbursement policies, and strong adoption of implantable and external defibrillators. The region also benefits from the presence of leading medical device manufacturers and well-established emergency medical response systems. For instance, in June 2024, the American Heart Association (AHA) projected that more than 61% of U.S. adults will have some form of cardiovascular disease by 2050, driven by population aging and increasing cardiovascular risk factors. The rising burden of cardiovascular disease is expected to increase demand for cardiac rhythm management devices and emergency defibrillation technologies across North America.

To learn more about this report, Download Free Sample Report

Asia Pacific Defibrillators Market Trends

Asia Pacific is expected to register the fastest CAGR during the forecast period, driven by the growing burden of cardiovascular diseases, expanding healthcare infrastructure, increasing healthcare expenditure, and improving access to advanced cardiac care. Rising awareness of sudden cardiac arrest, together with expanding electrophysiology services and favorable regulatory approvals, is supporting wider adoption of implantable and external defibrillators across the region. For instance, in October 2024, MicroPort CRM received approval from China's National Medical Products Administration (NMPA) for its locally manufactured PLATINIUM implantable cardioverter defibrillators (ICDs). The approval expands access to advanced ICD therapy in China and strengthens the availability of locally manufactured cardiac rhythm management devices across Asia Pacific.

Key Defibrillators Company Insights

The defibrillators market is highly competitive, with leading manufacturers focusing on technological innovation, product approvals, strategic acquisitions, and geographic expansion to strengthen their market presence. Companies are investing in next-generation implantable and external defibrillators with enhanced connectivity, remote monitoring, AI-enabled diagnostics, and improved therapeutic capabilities to meet the growing demand for advanced cardiac rhythm management solutions.

Key Defibrillators Companies

The following key companies have been profiled for this study on the defibrillators market:

• Medtronic plc

• Abbott Laboratories

• Boston Scientific Corporation

• BIOTRONIK SE & Co. KG

• MicroPort Scientific Corporation

• Koninklijke Philips N.V.

• Stryker Corporation

• ZOLL Medical Corporation

• Nihon Kohden Corporation

• SCHILLER AG

Recent Developments

• In April 2026, BIOTRONIK received U.S. FDA approval for its Rivacor Sky CRT-D and Acticor Sky ICD systems. The next-generation implantable defibrillators feature enhanced anti-tachycardia pacing (ATP), Left Bundle Branch Area Pacing (LBBAP) support, and DX Technology for atrial sensing without an additional atrial lead, strengthening the company's advanced cardiac rhythm management portfolio.
• In September 2025, Safe Life acquired AED Brands, a U.S. distributor of automated external defibrillators (AEDs), accessories, maintenance services, and cardiac emergency preparedness solutions. The acquisition expands Safe Life's distribution capabilities and strengthens its presence in the U.S. AED market.

Global Defibrillators Market Report Segmentation

This report forecasts revenue growth at the regional and country levels and provides an analysis of the latest industry trends and opportunities in each sub segment from 2021 to 2033. For this study, Grand View Research has segmented the global defibrillators market report on the basis of product, end use, and region.

• Product Outlook (Revenue, USD Billion, 2021 - 2033)

  • Implantable Cardioverter Defibrillators (ICD)

    • S-ICD

    • T-ICD

      • Single Chamber

      • Dual Chamber

      • CRT-D

  • External Defibrillators (ED)

    • Manual ED

    • Automated ED

    • Wearable Cardioverter Defibrillators

• End use Outlook (Revenue, USD Billion, 2021 - 2033)

  • Hospital

  • Pre-hospital

  • Public Access Market

  • Alternate Care Market

  • Home Healthcare

• Regional Outlook (Revenue, USD Billion, 2021 - 2033)

  • North America

    • U.S.

    • Canada

  • Europe

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • China

    • India

    • Japan

    • Australia

    • South Korea

    • Thailand

  • Latin America

    • Brazil

    • Mexico

    • Argentina

  • MEA

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait